Status and phase
Conditions
Treatments
About
The purpose of this Phase II study is to evaluate efficacy and safety of inhaled formoterol fumarate in the Pressair DPI compared to the Foradil Aerolizer in patients with mild to moderate asthma.
This study will include a screening visit followed by a 4 month treatment period.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusions:
Exclusions:
Primary purpose
Allocation
Interventional model
Masking
174 participants in 5 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal